1. Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial
- Author
-
Fabris, F., Pilger, E., Pabst, E., Kostner, G., Wautrecht, J. C., Baitsch, G., Breddin, K., Diehm, C., Podhaisky, H., Taute, B. M., Diamantoupolos, E. J., Aimar, T., Alari, G., Albano, S., Altamura, N., Arosio, E., Bortolon, M., Caccia, R., Carotta, M., Carzaniga, G., Catalano, M., Contini, P., Difolca, A., Dore, M., Falaschi, F., Franchini, B., Frare, C., Frascisco, M., Giansante, C., Giona, E., Giubbolini, M., Lucarelli, F., Marchitelli, E., Marcialis, M. R., Martignoni, A., Melillo, E., Minola, M., Monetti, D., Nenci, G., Paolicelli, M., Pasqualini, L., Perilli, E., Pettina, G., Poli, L., Radicchia, S., Rossi, M., Scandale, G., Scondotto, G., Sergi, D., Setacci, C., Spada, S., Todini, A. R., Vaudo, G., Verlato, F., Visona, A., Zannoni, M., Bielawiec, M., Jawien, A., Meissner, A., Michalak, J., Nizankowski, R., Wandzilak, M., Avram, J. A., Avram, R., Hancu, N., Marian, A., Marian, I., Murariu, M., Negrisanu, G., Olinic, D., Olinic, N., Trambitas, R., Veresiu, I., Victoria, I., Kozak, M., Mavri, A., Bahi, J. S., Bahi, P. S., Brunkwall, J., and Gallino, A.
- Subjects
Male ,medicine.medical_specialty ,Settore MED/09 - Medicina Interna ,Placebo ,law.invention ,Double-Blind Method ,Randomized controlled trial ,Ischemia ,law ,Internal medicine ,Internal Medicine ,medicine ,Humans ,Myocardial infarction ,Stroke ,Aged ,Angiology ,Peripheral Vascular Diseases ,Leg ,Aspirin ,Vascular disease ,business.industry ,Antioxidant vitamins ,Peripheral arterial disease ,Prevention ,medicine.disease ,Surgery ,Clinical trial ,Treatment Outcome ,Female ,business ,Platelet Aggregation Inhibitors ,medicine.drug - Abstract
OBJECTIVE: To assess the prophylactic efficacy of aspirin and a high-dose antioxidant vitamin combination in patients with peripheral arterial disease (PAD) in terms of reduction of the risk of a first vascular event (myocardial infarction, stroke, vascular death) and critical limb ischaemia. DESIGN: Randomized, placebo-controlled, double-blind clinical trial with 2 x 2 factorial design. SETTING: Thirty-seven European angiology/vascular medicine units. SUBJECTS: A total of 366 outpatients with stage I-II PAD documented by angiography or ultrasound, with ankle/brachial index
- Published
- 2007
- Full Text
- View/download PDF